Percutaneous Ethanol Sclerotherapy for Head-and-Neck Lymphatic Malformation: A Systematic Review and Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Lymphatic malformations (LMs) are one of the more commonly encountered cystic head-and-neck tumors. Surgical excision is the traditional treatment with inherent peri-operative risks. Alternative treatment of these tumors using percutaneous sclerotherapy agents has been proposed with no major consensus on the treatment approaches and sclerotherapy agent choices. This paper presents a systematic review of percutaneous ethanol sclerotherapy for neck lymphangioma and a case report of ethanol ablation in a patient with neck lymphangioma with good cosmesis results. Systematic review was conducted on PubMed using key words: “Ethanol” OR “Alcohol” AND “Ablation” OR “Sclerotherapy” OR “Sclerosing” AND “Lymphangioma” OR “Lymphatic Malformation” as per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Three hundred fifteen articles from initial PubMed search results were screened by titles and abstracts. Full text was retrieved. 3 studies were included in our systematic review. Overall evidence quality is modest with marked heterogeneity. All 12 patients treated with percutaneous ethanol sclerotherapy for head-and-neck LMs reported favorable response. Only 1 patient (8.3%) encountered a peri-procedural complication. Percutaneous ethanol sclerotherapy of neck lymphangioma in our patient also reported favorable response with no complications. Invasive treatment for LMs should be personalized and dependent on the availability of experienced operators/centers with appropriate volume in either primary excisional surgery or percutaneous sclerotherapy. Percutaneous ethanol sclerotherapy is an acceptable option with benefits of widespread availability and cost-effectiveness in our South-East Asia region. Limitations of our review are largely due to significant study heterogeneity.
Abstract
Lymphatic malformations (LMs) are one of the more commonly encountered cystic head-and-neck tumors. Surgical excision is the traditional treatment with inherent peri-operative risks. Alternative treatment of these tumors using percutaneous sclerotherapy agents has been proposed with no major consensus on the treatment approaches and sclerotherapy agent choices. This paper presents a systematic review of percutaneous ethanol sclerotherapy for neck lymphangioma and a case report of ethanol ablation in a patient with neck lymphangioma with good cosmesis results. Systematic review was conducted on PubMed using key words: “Ethanol” OR “Alcohol” AND “Ablation” OR “Sclerotherapy” OR “Sclerosing” AND “Lymphangioma” OR “Lymphatic Malformation” as per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Three hundred fifteen articles from initial PubMed search results were screened by titles and abstracts. Full text was retrieved. 3 studies were included in our systematic review. Overall evidence quality is modest with marked heterogeneity. All 12 patients treated with percutaneous ethanol sclerotherapy for head-and-neck LMs reported favorable response. Only 1 patient (8.3%) encountered a peri-procedural complication. Percutaneous ethanol sclerotherapy of neck lymphangioma in our patient also reported favorable response with no complications. Invasive treatment for LMs should be personalized and dependent on the availability of experienced operators/centers with appropriate volume in either primary excisional surgery or percutaneous sclerotherapy. Percutaneous ethanol sclerotherapy is an acceptable option with benefits of widespread availability and cost-effectiveness in our South-East Asia region. Limitations of our review are largely due to significant study heterogeneity.
참고문헌 (26)
- Burrows PE, "Percutaneous treatment of low flow vascular malformations", J Vasc Interv Radiol, 15, pp.431~445 (2004)
- "ISSVA classification of vascular anomalies" (2018)[URL]
- Fereydooni A, "Molecular changes associated with vascular malformations", J Vasc Surg, 70, pp.314~326 (2019)
- Martinez-Corral I, "Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation", Nat Commun, 11, pp.2869~ (2020)
- Yarso KY, "Ethanol ablation for management of large cyst hygroma colli in adult : a case report", Int J Surg Case Rep, 105, pp.108092~ (2023)
- Wiegand S, "Sclerotherapy of lymphangiomas of the head and neck", Head Neck, 33, pp.1649~1655 (2011)
- Yang CC, "Efficacy of ethanol ablation for benign thyroid cysts and predominantly cystic nodules : a systematic review and meta-analysis", Endocrinol Metab(Seoul), 36, pp.81~95 (2021)
- Fukumoto K, "Ethanol injection sclerotherapy for Baker’s cyst, thyroglossal duct cyst, and branchial cleft cyst", Ann Plast Surg, 33, pp.615~619 (1994)
- Puig S, "Double-needle sclerotherapy of lymphangiomas and venous angiomas in children : a simple technique to prevent complications", AJR Am J Roentgenol, 180, pp.1399~1401 (2003)
- Impellizzeri P, "Sclerotherapy for cervical cystic lymphatic malformations in children. Our experience with computed tomography-guided 98% sterile ethanol insertion and a review of the literature", J Pediatr Surg, 45, pp.2473~2478 (2010)
- Furukawa H, "Ethanol sclerotherapy with ‘injection and aspiration technique’ for giant lymphatic malformation in adult cases", J Plast Reconstr Aesthet Surg, 64, pp.809~811 (2011)
- Odeyinde SO, "Sclerotherapy for vascular malformations : complications and a review of techniques to avoid them", J Plast Reconstr Aesthet Surg, 66, pp.215~223 (2013)
- Perkins JA, "Lymphatic malformations : review of current treatment", Otolaryngol Head Neck Surg, 142, pp.795~803 (2010)
- Kennedy TL, "Cystic hygroma", lymphangioma : a rational approach to management, 2001, pp.111, 1929~1937
- Balakrishnan K, "Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations", JAMA Otolaryngol Head Neck Surg, 140, pp.41~45 (2014)
- Horbach SE, "Sclerotherapy for low-flow vascular malformations of the head and neck : a systematic review of sclerosing agents", J Plast Reconstr Aesthet Surg, 69, pp.295~304 (2016)
- Albanese G, "Pharmacology of sclerotherapy", Semin Intervent Radiol, 27, pp.391~399 (2010)
- Shiels WE 2nd, "Percutaneous treatment of lymphatic malformations", Otolaryngol Head Neck Surg, 141, pp.219~224 (2009)
- Mason KP, "Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies", Radiology, 217, pp.127~132 (2000)
- Perkins JA, "New frontiers in our understanding of lymphatic malformations of the head and neck : natural history and basic research", Otolaryngol Clin North Am, 51, pp.147~158 (2018)
- Wiegand S, "Treatment of lymphatic malformations with the mTOR inhibitor sirolimus : a systematic review", Lymphat Res Biol, 16, pp.330~339 (2018)
- Adams MT, "Head and neck lymphatic malformation treatment : a systematic review", Otolaryngol Head Neck Surg, 147, pp.627~639 (2012)
- de Serres LM, "Lymphatic malformations of the head and neck. A proposal for staging", Arch Otolaryngol Head Neck Surg, 121, pp.577~582 (1995)
- Wiegand S, "Evaluation of children with lymphatic malformations of the head and neck using the Cologne Disease Score", Int J Pediatr Otorhinolaryngol, 73, pp.955~958 (2009)
- Page MJ, "The PRISMA 2020 statement : an updated guideline for reporting systematic reviews", Int J Surg, 88, pp.105906~ (2021)
- Shea BJ, "AMSTAR 2 : a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both", BMJ, 358, pp.j4008~ (2017)